Columnist Lara Govendo celebrates two years of marriage this week, and is grateful to her husband during this year's health ups and downs https://t.co/ijHXlTExik #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
A review paper highlights the unique psychological challenges that adults with cystic fibrosis face when deciding to become parents. https://t.co/RG2XsKX17H #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Immune abnormalities linked to lung damage in CF may begin in early childhood and persist despite treatment, a study in Australia suggests. https://t.co/pZMQSBmqM7 #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Columnist Jennifer Cogliano honors the strength of the cystic fibrosis community by reflecting on progress made, and progress still needed. https://t.co/201hMDcfp4 #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Immune cells that patrol the lungs may help sustain persistent lung inflammation in CF despite treatment with CFTR modulators, per a study. https://t.co/DwyMJfyIrm #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Columnist Ed Jordan explains how building a routine helped organize the chaos when he was raising his late daughter, who had CF. https://t.co/PvSwiixmeS #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
People with cystic fibrosis treated with CFTR modulators have a significantly lower risk of death than untreated patients, a study reports. https://t.co/3JZwNzVMDo #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Data from CGM devices can reveal early signs of diabetes in people with CF who test negative with standard tools, a study found. https://t.co/nvvFSs6YFp #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
In a small clinical trial, Enterprise's inhaled CF treatment ETD001 improved lung function in patients not taking CFTR modulators. https://t.co/sX2mwrdbZq #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Blackstone Life Sciences is investing $250 million in Anagram Therapeutics' ANG003, a treatment for exocrine pancreatic insufficiency in CF. https://t.co/cl9Bae2vsS #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
An early trial testing the inhaled CF treatment VX-522 was stopped due to tolerability issues, leading Vertex to terminate its development. https://t.co/uMQWe1JJq9 #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Columnist Jennifer Cogliano explains why seeking help from attorneys with CF-specific knowledge is crucial during disability reviews. https://t.co/pE8JkYZCB5 #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Columnist Lara Govendo reminds readers that, while she is a person with cystic fibrosis, she is more than the disease she was diagnosed with. https://t.co/tjVW3NIYnj #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
A U.S. study links a family history of diabetes, especially type 2, to a higher risk of cystic fibrosis-related diabetes in adults with CF. https://t.co/xR4kvY73fB #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
CF children with two Trikafta-responsive mutations showed stronger reductions in sweat chloride levels than those with just one, per a study. https://t.co/2bQPnqRKwn #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Since CF can't be cured or reversed, columnist Jennifer Cogliano questions why those who qualify for disability benefits need ongoing reviews. https://t.co/QUKmfQNaKG #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
Columnist Lara Govendo is returning to the Transplant Games of America, and this time she will be playing pickleball and basketball. https://t.co/8mrebCP5DJ #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife
May is Cystic Fibrosis Awareness Month. Discover how advocates in the U.S., Canada, and Ireland are launching events to fund research. https://t.co/6JXfwY3fOQ #cysticfibrosis#cfwarrior#curecf#cysticfibrosislife